Empirico

Empirico is a clinical-stage biotechnology company that discovers and develops siRNA medicines designed to mimic naturally-occurring genetic variants that confer beneficial effects on health and disease. Empirico’s two foundational and proprietary technology platforms - the Precision Insights Platform™ for genetically-validated target discovery, and the siRCH™ platform for the discovery and development of siRNA medicines - enable Empirico and its collaborators to rapidly advance programs from the discovery and validation of novel targets to clinically-viable therapeutics. Empirico’s exceptional internal capabilities, augmented by those of its partners, are driving the advancement of a growing and differentiated pipeline of wholly-owned and partnered programs for a broad range of common diseases with unmet medical need. Empirico is headquartered in San Diego, CA with a major second R&D site in Madison, WI.

Website

https://www.empiri.co

External link for Empirico

Industry

Biotechnology

Company size

51-200 employees

Headquarters

San Diego, CA

Type

Privately Held